BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28422065)

  • 1. Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients.
    Levesque E; Rizk F; Noorah Z; Aït-Ammar N; Cordonnier-Jourdin C; El Anbassi S; Bonnal C; Azoulay D; Merle JC; Botterel F
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.
    Alexander BD; Smith PB; Davis RD; Perfect JR; Reller LB
    J Clin Microbiol; 2010 Nov; 48(11):4083-8. PubMed ID: 20720025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.
    Azoulay E; Guigue N; Darmon M; Mokart D; Lemiale V; Kouatchet A; Mayaux J; Vincent F; Nyunga M; Bruneel F; Rabbat A; Bretagne S; Lebert C; Meert AP; Benoit D; Pene F
    Oncotarget; 2016 Apr; 7(16):21484-95. PubMed ID: 26910891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of (1,3)-beta-D-glucan to diagnosis of invasive candidiasis after liver transplantation.
    Levesque E; El Anbassi S; Sitterle E; Foulet F; Merle JC; Botterel F
    J Clin Microbiol; 2015 Mar; 53(3):771-6. PubMed ID: 25520448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
    Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
    Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
    Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
    Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance Characteristics of Galactomannan and β-d-Glucan in High-Risk Liver Transplant Recipients.
    Singh N; Winston DJ; Limaye AP; Pelletier S; Safdar N; Morris MI; Meneses K; Busuttil RW; Wagener MM; Wheat LJ
    Transplantation; 2015 Dec; 99(12):2543-50. PubMed ID: 26050015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
    Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
    Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections.
    Verma N; Singh S; Taneja S; Duseja A; Singh V; Dhiman RK; Chakrabarti A; Chawla YK
    Liver Int; 2019 Mar; 39(3):503-513. PubMed ID: 30276951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
    Cento V; Alteri C; Mancini V; Gatti M; Lepera V; Mazza E; Moioli MC; Merli M; Colombo J; Orcese CA; Bielli A; Torri S; Gasparini LE; Vismara C; De Gasperi A; Brioschi P; Puoti M; Cairoli R; Lombardi G; Perno CF
    Mycoses; 2020 Dec; 63(12):1299-1310. PubMed ID: 32810888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
    Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
    Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Analysis for Invasive Fungal Infection after Living Donor Liver Transplantation: Which Patient Needs Potent Prophylaxis?
    Utsumi M; Umeda Y; Yagi T; Nagasaka T; Shinoura S; Yoshida R; Nobuoka D; Kuise T; Fuji T; Takagi K; Takaki A; Fujiwara T
    Dig Surg; 2019; 36(1):59-66. PubMed ID: 29649828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation.
    Reischies FM; Prattes J; Woelfler A; Eigl S; Hoenigl M
    Transpl Infect Dis; 2016 Jun; 18(3):466-70. PubMed ID: 26992092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.
    Zheng F; Zha H; Yang D; Deng J; Zhang Z
    Mycopathologia; 2017 Apr; 182(3-4):331-338. PubMed ID: 27664106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.
    Ostrosky-Zeichner L; Alexander BD; Kett DH; Vazquez J; Pappas PG; Saeki F; Ketchum PA; Wingard J; Schiff R; Tamura H; Finkelman MA; Rex JH
    Clin Infect Dis; 2005 Sep; 41(5):654-9. PubMed ID: 16080087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.
    Senn L; Robinson JO; Schmidt S; Knaup M; Asahi N; Satomura S; Matsuura S; Duvoisin B; Bille J; Calandra T; Marchetti O
    Clin Infect Dis; 2008 Mar; 46(6):878-85. PubMed ID: 18260755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
    Persat F; Ranque S; Derouin F; Michel-Nguyen A; Picot S; Sulahian A
    J Clin Microbiol; 2008 Mar; 46(3):1009-13. PubMed ID: 18160456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever.
    Ellis M; Al-Ramadi B; Finkelman M; Hedstrom U; Kristensen J; Ali-Zadeh H; Klingspor L
    J Med Microbiol; 2008 Mar; 57(Pt 3):287-295. PubMed ID: 18287290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of plasma (1, 3)-beta-D glucan assay for invasive fungal infections in patients with hematological disorders].
    Liu F; Wu T; Cai P; Liu Y; Lu Y; Zhou JR; Yang F; Liu Q; Gao YQ; Luo RM; Zhang JP; Sun Y; Cao XY; Yin YM; Zhao YL; Wang JB; Tong CR; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1043-6. PubMed ID: 19698256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of plasma beta-Glucan in early diagnosis of invasive fungal infection in children].
    Zhao L; Tang JY; Wang Y; Zhou YF; Chen J; Li BR; Xue HL
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov; 11(11):905-8. PubMed ID: 20113658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.